Ascendis Pharma
ASND
ASND
188 hedge funds and large institutions have $9.19B invested in Ascendis Pharma in 2024 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 73 increasing their positions, 50 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 16 → 16 (0)
0.31% less ownership
Funds ownership: 105.66% → 105.35% (-0.31%)
7% less call options, than puts
Call options by funds: $48.3M | Put options by funds: $51.8M
Holders
188
Holding in Top 10
16
Calls
$48.3M
Puts
$51.8M
Top Buyers
| 1 | +$139M | |
| 2 | +$51.3M | |
| 3 | +$50.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$43.2M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$35.4M |
Top Sellers
| 1 | -$215M | |
| 2 | -$76M | |
| 3 | -$34.4M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
-$32.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.6M |